Pharmacist

Resource

Engagement Academy: our courses on engaging children and young people

We offer a range of online and in-person courses for heath workers so your services can help 0-25 year olds develop and thrive.

Engaging children and young people

Continuing professional development

News

An interview with the PADDINGToN team, who wins the RCPCH-NIHR PIER Prize 2024

30 January 2025

The RCPCH-NIHR PIER (Paediatric Involvement and Engagement in Research) Prize recognises significant contributions to excellent patient engagement for NIHR Clinical Research Network Portfolio studies.

Resource

Medication safety: Management of the supply of unlicensed liquid medicines to children - recommendations for implementation

NHS England tasked the RCPCH/NPPG Medicines Committee to improve the safety of liquid medicines during the transition from hospital to home care. This follows several serious incidents, including the death of a child due to confusion over liquid morphine strengths. Mistakes can occur because of t...

Drugs and medicines

Patient safety

Resource

Medicines for Children - information for parents and carers

Our website provides practical and reliable information to parents and carers about giving medicines to their child - with free access to information leaflets on over 200 medicines, videos and news.

Drugs and medicines

Patient information

Resource

Medicine dosing in childhood obesity

UK Medicines Information service (UKMI) in conjunction with the Neonatal and Paediatric Pharmacy Group (NPPG) have produced updated guidance on how to dose medication in children who are obese.

Drugs and medicines

Obesity

Patient safety

Resource

Standardising intravenous infusion concentrations for neonates and children in the UK - framework

This framework (updated in November 2024) is developed by Neonatal and Paediatric Pharmacy Group (NPPG), with support from RCPCH, Paediatric Critical Care Society (PCCS) and British Association of Perinatal Medicine (BAPM).

Drugs and medicines

Patient safety

News

Medicine safety alert - ranitidine (withdrawn)

10 February 2021

Ranitidine products (Brand names including Zantac®) were voluntarily withdrawn by manufacturers in October 2019 due to the presence of low levels of an impurity called NDMA. The European Medicines Agency has since confirmed its recommendation to suspend all ranitidine medicines in the EU.

Resource

Antiepileptic drugs: review of safety of use during pregnancy

Following the known harms of valproate in pregnancy, MHRA released a report looking into the safety data for epilepsy medicines during pregnancy.

Resource

Choosing an oral liquid medicine for children - position statement (endorsed)

We are very pleased to announce the publication of this latest position statement produced by the Neonatal and Paediatric Pharmacy Group (NPPG) and endorsed by the Royal College of Paediatrics and Child Health (RCPCH) regarding how to choose an oral liquid for a child.

Drugs and medicines

Patient safety

News

Medicines safety alert – apraclonidine use in infants below six months of age

17 March 2020

The RCPCH/NPPG Medicines Committee has recently been informed of a severe adverse reaction in a six-month old child with anisocoria who had been administered apraclonidine 1% to help exclude Horner syndrome.